| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in medical treatments demonstrate a strong commitment to innovation in pharmaceuticals, particularly with impressive clinical results and long-term outcomes for therapies like nipocalimab. This trend is further bolstered by new treatment regimens in cancer therapies and specific innovations targeting adolescent health issues. Significant improvements in patient safety and efficacy profiles continually highlight Johnson & Johnson's role in transforming treatment landscapes. Overall, these developments indicate a positive trajectory in enhancing patient health outcomes across various conditions. |
| The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-04-10. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.7) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| JNJ | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-10 | 0%(0%) | 0 | 0% | 0.3 | 2.7 | -1 | |||||||
| 2025-04-09 | 0%(0%) | 0 | 0% | 0.3 | 2.5 | -1 | |||||||
| 2025-04-08 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-04-07 | 0%(0%) | 0 | 0% | 0 | 1 | -1 | |||||||
| 2025-04-04 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-04-03 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-04-02 | 0%(0%) | 0 | 0% | -0.2 | 0.1 | -1 | |||||||
| 2025-04-01 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-03-31 | 0%(0%) | 0 | 0% | -0.5 | -1.8 | -1 | |||||||
| 2025-03-28 | 0%(0%) | 0 | 0% | -0.4 | -1.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-06-11 22:22:16 Emerging treatments addressing adolescent health issues, particularly in dermatological conditions, showcasing progress in health outcomes. |
| 2025-06-11 22:22:16 An exploration of the challenges posed by stock market fluctuations and the opportunities they present for investors. |
| 2025-06-11 22:22:16 Strategies employed by investors, focusing on acquiring stocks during sell-offs and the potential for passive income generation. |
| 2025-06-11 22:22:16 Advancements in medical treatments and therapies, particularly new drug results and their safety and efficacy profiles. |
| 2025-06-11 22:22:16 Discussion around the expected financial performance and earnings projections of companies, particularly focusing on metrics beyond standard estimates. |